These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3183961)

  • 1. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
    Bousselmame R; Eustache M; Michael-Titus A; Costentin J
    Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
    De la Baume S; Schwartz JC
    Eur J Pharmacol; 1988 Apr; 149(1-2):121-9. PubMed ID: 3165067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
    Gros C; Souque A; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
    Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
    Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
    Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
    Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of two probes for the localisation of enkephalinase in rat brain: [3H]thiorphan and a 125I-labeled monoclonal antibody.
    Pollard H; De la Baume S; Bouthenet ML; Schwartz JC; Ronco P; Verroust P
    Eur J Pharmacol; 1987 Jan; 133(2):155-64. PubMed ID: 3545855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [125I]atrial natriuretic factor to mouse lung membranes in vivo: characterization and effects of peptidase inhibitors.
    Souque A; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1373-8. PubMed ID: 1532034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP
    J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an enkephalinase inhibitor on esophageal motility in man.
    Chaussade S; Hamm R; Lecomte JM; Couturier D; Guerre J
    Gastroenterol Clin Biol; 1988 Nov; 12(11):793-6. PubMed ID: 3220232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor.
    Jivegård L; Pollard H; Moreau J; Schwartz JC; Thune A; Svanvik J
    Clin Sci (Lond); 1989 Jul; 77(1):49-54. PubMed ID: 2758762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
    Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
    Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.